Natraj Proteins Board of Directors
Get the latest insights into the leadership at Natraj Proteins. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Kailash Chand Sharma | Chairman & Managing Director |
| Mr. Sharad Kumar Jain | Whole Time Director |
| Mr. Praneet Mishra | Ind. Non-Executive Director |
| Mr. Vishal Kumar | Ind. Non-Executive Director |
| Mr. Rajender Singh Tomar | Ind. Non-Executive Director |
| Mrs. Namita Sharma | Non Executive Woman Director |
Natraj Proteins Share price
NATRAJPR
39.4
0.76 (-1.89%)Last updated on 4 Sep, 2025 | 14:45 IST
BUYSELL
Today's High
43.60
Today's Low
39.15
52 Week Low
32.35
52 Week High
60.00
The current prices are delayed, login to your account for live prices
LoginNatraj Proteins FAQs
The board at Natraj Proteins consists of experienced professionals, including Mr. Kailash Chand Sharma , Mr. Sharad Kumar Jain , and others, overseeing the company’s strategic and corporate governance.
Directors at Natraj Proteins are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Kailash Chand Sharma is the current chairman at Natraj Proteins.
Executive directors at Natraj Proteins are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Natraj Proteins adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Natraj Proteins, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.